Application for import and use of genetically modified herbicide tolerant maize Event GA21 under Regulation (EC) No 1829/2003 PART II: SUMMARY

Size: px
Start display at page:

Download "Application for import and use of genetically modified herbicide tolerant maize Event GA21 under Regulation (EC) No 1829/2003 PART II: SUMMARY"

Transcription

1 Syngenta Event GA21 Page 1 of 29 Application for import and use of genetically modified herbicide tolerant maize Event GA21 under Regulation (EC) No 1829/2003

2 Syngenta Event GA21 Page 2 of 29 A. GENERAL INFORMATION 1. Details of application a) Member State of application UK b) Application number Not available at the time of submission c) Name of the product (commercial and other names) Maize Event GA21 In the USA, GA21 is marketed under the product name Agrisure GT Advantage ( d) Date of acknowledgement of valid application Not available at the time of submission

3 Syngenta Event GA21 Page 3 of Applicant a) Name of applicant Syngenta Seeds S.A.S on behalf of Syngenta Crop Protection AG, Basel b) Address of applicant Syngenta Seeds S.A.S. 12, chemin de l'hobit BP 27 F Saint-Sauveur On behalf of Syngenta Crop Protection AG, Basel Switzerland and all affiliated companies Schwarzwaldallee 215 CH 4058 Basle Switzerland c) Name and address of the person established in the Community who is responsible for the placing in the market, whether it be the manufacturer, the importer or the distributor, if different from the applicant (Commission Decision 2004/204/EC Art 3(a)(ii)) Event GA21 maize will be imported and used as any other maize in the EU by operators currently involved in these processes. 3. Scope of the application GM plants for food use Food containing or consisting of GM plants Food produced from GM plants or containing ingredients produced from GM plants GM plants for feed use Feed containing or consisting of GM plants Feed produced from GM plants Import and processing (Part C of Directive 2001/18/EC) Seeds and plant propagating material for cultivation in Europe (Part C of Directive 2001/18/EC)

4 Syngenta Event GA21 Page 4 of Is the product being simultaneously notified within the framework of another regulation (e.g. Seed legislation?)? Yes By Monsanto No By Syngenta If yes, specify An application made by Monsanto under Regulation (EC) No 258/97 is pending approval. Additionally, GA21 has been entered on the community register of GM Food and Feed as an Existing product under Article 8 and 20 of Regulation (EC) No 1829/ Has the GM plant been notified under Part B of Directive 2001/18/EC and/or Directive 90/220/EEC? Yes By companies other than Syngenta No By Syngenta If no, refer to risk analysis data on the basis of the elements of Part B of Directive 2001/18/EC 6. Has the GM plant or derived products been previously notified for marketing in the Community under Part C of Directive 2001/18/EC or Regulation (EC) 258/97? Yes By Monsanto No By Syngenta If yes, specify Applications for commercial approval were made by Monsanto under Directive 90/220/EEC but have been withdrawn. An application by Monsanto under Regulation (EC) No 258/97 is pending approval. Additionally, GA21 has been entered on the community register of GM Food and Feed as an Existing product under Article 8 and 20 of Regulation (EC) No 1829/ Has the product been notified in a third country either previously or simultaneously? Yes No If yes, specify Event GA21 is approved for cultivation in the USA, Canada and Japan. It is approved for feed use in USA, Canada, South Africa, Japan, Philippines and China and food use in USA, Canada, Mexico, Japan, South Africa, Australia, New Zealand, Korea, Philippines, Taiwan

5 Syngenta Event GA21 Page 5 of 29 and China. 8. General description of the product a) Name of the recipient or parental plant and the intended function of the genetic modification Event GA21 is a genetically modified (GM) maize, which expresses a mutated maize 5- enolpyruvylshikimate-3-phosphate synthase enzyme (mepsps). EPSPS is a key enzyme in the shikimic acid pathway, involved in the biosynthesis of aromatic amino acids and is naturally found in all plants, fungi, and bacteria but absent in animals. EPSPS is highly sensitive to herbicide products containing glyphosate. Maize plants transformed with the mutated epsps (mepsps) gene, such as those derived from Event GA21, synthesize the mepsps protein that confers tolerance to herbicide products containing glyphosate. b) Types of products planned to be placed on the market according to the authorisation applied for The scope of the application includes all feed and food products containing, consisting or produced from the genetically modified maize Event GA21 including products from inbreds and hybrids obtained by conventional breeding of Event GA21. The application also covers the import and industrial processing of Event GA21 maize for all potential uses as any other maize. c) Intended use of the product and types of users Use as any other conventional maize d) Specific instructions and/or recommendations for use, storage and handling, including mandatory restrictions proposed as a condition of the authorisation applied for The characteristics of Event GA21 maize and products derived from it are not different from those of its conventional counterpart, apart from the introduced trait of tolerance to herbicide products containing glyphosate. Event GA21 has been shown to be as safe and as wholesome as existing varieties of maize. Therefore there are no specific instructions or recommendations for use, storage and handling of Event GA21 maize. e) Any proposed packaging requirements The characteristics of Event GA21 maize and products derived from it are not different from those of its conventional counterpart. Event GA21 has been shown to be as safe and as

6 Syngenta Event GA21 Page 6 of 29 those of its conventional counterpart. Event GA21 has been shown to be as safe and as wholesome as existing varieties of maize. Therefore there are no specific instructions for packaging. f) A proposal for labelling in accordance with Articles 13 and Articles 25 of Regulation (EC) 1829/2003. In the case of GMOs, food and/or feed containing or consisting of GMOs, a proposal for labelling has to be included complying with the requirements of Article 4, B(6) of Regulation (EC) 1830/2003 and Annex IV of Directive 2001/18/EC A proposal for labelling has been included in the application following the guidance provided by EFSA. This includes the labelling requirements outlined by Regulation (EC) No 1829/2003 and Annex IV of Directive 2001/18/EC. Event GA21 maize grain will therefore be labelled as genetically modified maize and products derived from it will be labelled as containing (or produced from) genetically modified maize. Since Event GA21 maize and products derived from it are not different from those of its conventional counterpart, no additional labelling is required. g) Unique identifier for the GM plant (Regulation (EC) 65/2004; does not apply to applications concerning only food and feed produced from GM plants, or containing ingredients produced from GM plants) A unique identifier for Event GA21 has been already assigned in accordance with Commission Regulation (EC) 65/2004: MON h) If applicable, geographical areas within the EU to which the product is intended to be confined under the terms of the authorisation applied for. Any type of environment to which the product is unsuited Event GA21 maize is suitable for use as any other maize under the terms of the authorisation applied for. 9. Measures suggested by the applicant to take in case of unintended release or misuse as well as measures for disposal and treatment Maize is incapable of sustained reproduction outside domestic cultivation and is noninvasive of natural habitats. The characteristics of Event GA21 maize and products derived from it are not different from those of its conventional counterpart, apart from the intended effect of tolerance to herbicide products containing glyphosate. Cultivation of Event GA21 in the EU is not within the scope of this application. In the unlikely event that small amounts of maize kernels of Event GA21 accidentally found their way into the environment this would represent extremely low levels of exposure and the survival of these kernels to produce flowering plants would be very unlikely. In addition, volunteers could be easily controlled using any of the current agronomic measures taken to control other commercially available maize such as cultivation and the use of selective herbicides.

7 Syngenta Event GA21 Page 7 of 29 Event GA21 has been shown to be as safe and as wholesome as existing varieties of maize. Any unintended releases or misuse can be dealt with in the same way as any other conventional maize.

8 Syngenta Event GA21 Page 8 of 29 B. INFORMATION RELATING TO THE RECIPIENT OR (WHERE APPROPRIATE) PARENTAL PLANTS 1. Complete name a) Family name Poaceae (formerly Gramineae) b) Genus Zea c) Species mays d) Subspecies mays e) Cultivar/breeding line or strain Event GA21 f) Common name Maize; corn 2 a. Information concerning reproduction (i) Mode(s) of reproduction Sexual reproduction: Zea mays is an allogamous plant that propagates through seed produced predominantly by cross-pollination and depends mainly on wind borne cross-fertilisation. Z. mays is a plant with protandrous inflorescence; however, decades of conventional selection and improvement have produced varieties of maize with protogynous traits. Z. mays has staminate flowers in the tassels and pistillate flowers on the ear shoots. There is no asexually reproductive maize. (ii) Specific factors affecting reproduction The key critical stages of maize reproduction are tasselling, silking, pollination and fertilization. Pollen dispersal is limited by several factors, including large size (0.1 mm diameter), rapid settling rate and short survivability. Most maize varieties are protoandrous so pollen shedding precedes silk emergence by up to five days. More than 98% of the pollen settles to the ground within a maximum distance of meters of its source. Shed pollen typically remains viable for 10 to 30 minutes, but may remain viable longer under refrigerated

9 Syngenta Event GA21 Page 9 of 29 and humid conditions. (iii) Generation time Maize is an annual crop. The generation time from sowing to harvesting varies according to the genetic background and the climate, it can range from as short as 60 to 70 days to as long as 43 to 48 weeks from seedling emergence to maturity. 2 b. Sexual compatibility with other cultivated or wild plant species Other cultivated plant species: The sexual compatibility of maize with other cultivated plant species is limited to Zea species. Wild plant species: No wild relatives of maize are present in Europe. Therefore, maize cannot exchange genes with any other wild species in the EU. 3. Survivability a) Ability to form structures for survival or dormancy Maize is an annual crop. Seeds are the only survival structures; they cannot be dispersed without mechanical disruption of the cobs and show little or no dormancy. Natural regeneration from vegetative tissue is not known to occur. b) Specific factors affecting survivability Survival of maize is dependent upon temperature, seed moisture, genotype, husk protection and stage of development. Maize cannot persist as a weed. Maize seed can only survive under a narrow range of climatic conditions. Volunteers are killed by frost or easily controlled by current agronomic practices including cultivation and the use of selective herbicides. Maize is incapable of sustained reproduction outside of domestic cultivation and is non-invasive of natural habitats. 4. Dissemination a) Ways and extent of dissemination Maize dissemination can only be accomplished through seed dispersal. Seed dispersal does not occur naturally due to the structure of the ear. b) Specific factors affecting dissemination

10 Syngenta Event GA21 Page 10 of 29 Maize has a polystichous (arranged in many rows) female inflorescence (flower), called the ear, on a stiff central spike (cob) enclosed in husks (modified leaves). Because of the structure of the ears, seed dispersal of individual kernels does not occur naturally. Maize is non-invasive of natural habitats. 5. Geographical distribution and cultivation of the plant, including the distribution in Europe of the compatible species Maize, which has very diverse morphological and physiological traits, is grown on approximately 147 million hectares worldwide. It is distributed over a wide range of conditions: from 56º N Lat to 40º S Lat, below sea level of the Caspian plains up to 3000 m in the Andes Mountains and from semi-arid regions to arid regions. The greatest maize production occurs where the warmest month isotherms range between 21º and 27º C and the freeze-free season lasts days. There are no wild relatives of maize in Europe. 6. In the case of plant species not normally grown in the Member State(s), description of the natural habitat of the plant, including information on natural predators, parasites, competitors and symbionts Maize was introduced into Europe in the 15 th century by Columbus and is widely grown in the European Union Member States. 7. Other potential interactions, relevant to the GM plant, of the plant with organisms in the ecosystem where it is usually grown, or used elsewhere, including information on toxic effects on humans, animals and other organisms Maize is known to interact with other organisms in the environment including insects, birds, and mammals. It is susceptible to a range of fungal diseases and insect pests, as well as to competition from surrounding weeds. Maize is extensively cultivated and has a history of safe use for human food and animal feed. No significant native toxins are reported to be associated with the genus Zea.

11 Syngenta Event GA21 Page 11 of 29 C. INFORMATION RELATING TO THE GENETIC MODIFICATION 1. Description of the methods used for the genetic modification Event GA21 was produced via microprojectile bombardment of maize suspension culture cells. 2. Nature and source of the vector used A NotI restriction fragment from the Plasmid pdpg434, was used to transform Event GA21 via microprojectile bombardment transformation. The plasmid is derived from a psk- vector which is commonly used in molecular biology and is derived from puc Source of donor DNA, size and intended function of each constituent fragment of the region intended for insertion Event GA21 is a genetically modified (GM) maize tolerant to herbicide products containing glyphosate. The DNA used in the transformation process, which resulted in Event GA21, was contained within a NotI restriction fragment and the components are shown below. The NotI restriction fragment contains the modified 5-enolpyruvylshikimate-3- phosphate synthase (mepsps) expression cassette but does not contain the origin of replication, the bla gene or the partial lacz sequence from the plasmid pdpg434. Vector Component Rice actin promoter and intron Approx. Size (Kb) Description region of the rice actin 1 gene containing the promoter and first exon and intron provides constitutive expression of the mepsps gene in maize. Optimised transit peptide Modified maize EPSPS gene 0.4 Optimised transit peptide sequence constructed based on transit peptide sequences from maize and sunflower ribulose-1,5-bis phosphate carboxylase oxygenase (RuBisCo) genes. 1.3 Nos 3 end 0.3 Mutated epsps gene, which confers resistance to herbicide products containing glyphosate. Polyadenylation region from the nopaline synthase gene from Agrobacterium tumefaciens.

12 Syngenta Event GA21 Page 12 of 29 D. INFORMATION RELATING TO THE GM PLANT 1. Description of the trait(s) and characteristics which have been introduced or modified Event GA21 maize contains a modified EPSPS enzyme (mepsps) that confers tolerance to herbicide products containing glyphosate. 2. Information on the sequences actually inserted or deleted a) The copy number of all detectable inserts, both complete and partial The entire Event GA21 insert and flanking regions have been sequenced. It has been shown that the insert is comprised of six contiguous regions derived from the 3.4 kb NotI restriction fragment from pdpg434 employed in the generation of Event GA21 (copies 1-6). Copy 1 contains the rice actin promoter that has a 5 deletion of 696 bp, the actin first exon and intron, the optimized transit peptide, the mepsps gene and the NOS terminator. Copies 2, 3 and 4 are intact versions of the 3.4 kb NotI restriction fragment from pdpg434. Copy 5 contains a complete rice actin promoter, the actin first exon and intron, the optimized transit peptide and the first 288 bp of the mepsps gene which ends in a stop codon and does not contain the NOS terminator. Copy 6 contains the rice actin promoter and a truncated actin first exon only and contains no other elements from pdpg434. In addition to sequencing, southern analysis has been performed to demonstrate the absence of further copies of the insert or vector sequence elsewhere in the genome. b) In case of deletion(s), size and function of the deleted region(s) Not applicable c) Chromosomal location(s) of insert(s) (nucleus, chloroplasts, mitochondria, or maintained in a non-integrated form), and methods for its determination The inheritance pattern of the insert in Event GA21 was investigated. Statistical analysis confirmed the expected Mendelian inheritance ratio for the mepsps gene, showing that insertion had taken place in the nuclear genome. d) The organisation of the inserted genetic material at the insertion site The entire insert and the 5 and 3 flanking regions were sequenced. The organisation of the insert is described in Section D2 (a) above. Based on the flanking sequence data, four putative open reading frames (ORFs) were identified. Two of these were encoded solely

13 Syngenta Event GA21 Page 13 of 29 within the maize DNA at the 3 of the GA21 insert. Due to the proximity of these putative ORFs with the truncated rice actin first exon, these putative ORFs were examined for homology to known toxins or allergens. No homology with known toxins or allergens in the database could be found. The remaining two putative ORFs were identified at the 5 end of the GA21 insert within the flanking region. These putative ORFs were analysed for homology to known toxins or allergens. No homology with known toxins or allergens in the database could be found. 3. Information on the expression of the insert a) Information on developmental expression of the insert during the life cycle of the plant To characterize the range of expression of the mepsps protein in maize plants derived from Event GA21, the concentrations of the protein was determined by ELISA at four growth stages (whorl, anthesis, seed maturity and senescence). Quantifiable concentrations of mepsps protein were detected in most Event GA21-derived plant tissues. Across all growth stages, mean mepsps concentrations measured in leaves, roots and whole plants ranged from below the limit of quantification (<0.2 µg/gfw) to ca. 15 µg/gfw (< µg/gdw). Mean mepsps concentrations measured in kernels ranged from ca. 4 7 µg/gfw(5 10 µg/gdw) and in pollen averaged ca. 168 µg/gfw. The concentrations of mepsps were generally similar between hybrids for each tissue type at each time point. b) Parts of the plant where the insert is expressed To characterize the range of expression of proteins in maize plants derived from Event GA21, the concentrations of these proteins were determined by ELISA in several plant tissues (leaves, roots, kernels, pollen and whole plants). Quantifiable concentrations of mepsps protein were detected in most Event GA21-derived plant tissues. 4. Information on how the GM plant differs from the recipient plant in a) Reproduction No changes in the reproduction, dissemination or survivability compared to non-gm maize have been observed in agronomic assessments conducted with Event GA21. b) Dissemination

14 Syngenta Event GA21 Page 14 of 29 No changes in the reproduction, dissemination or survivability compared to non-gm maize have been observed in agronomic assessments conducted with Event GA21. c) Survivability No changes in the reproduction, dissemination or survivability compared to non-gm maize have been observed in agronomic assessments conducted with Event GA21. d) Other differences No changes in the reproduction, dissemination or survivability compared to non-gm maize have been observed in agronomic assessments conducted with Event GA Genetic stability of the insert and phenotypic stability of the GM plant Genetic stability: Southern analysis of DNA derived from several generations of Event GA21 plants was conducted to confirm a single insertion site. The hybridisation data demonstrate that the insert incorporated into Event GA21 is stable over several generations. Phenotypic stability: The stability of mepsps protein expression over multiple generations was evaluated. Seed from three backcross generations was grown under greenhouse conditions and leaf material was collected at anthesis for analysis of mepsps protein concentrations. Mean mepsps concentrations measured across all backcross generations were ca µg/gfw (82 96 µg/gdw). Overall, mepsps concentrations were similar across the three generations analyzed, demonstrating stable expression of mepsps protein across multiple generations. 6. Any change to the ability of the GM plant to transfer genetic material to other organisms a) Plant to bacteria gene transfer The horizontal gene transfer from GM plants to bacteria with subsequent expression of the transgene is regarded as a highly unlikely event under natural conditions, especially in the absence of selective pressure, and would occur primarily through homologous recombination in microbes 1. The mepsps gene is under the control of a plant promoter and epsps genes are 1 EFSA, 2004c. Opinion of the Scientific Panel on Genetically Modified Organisms on the use of antibiotic resistance genes as marker genes in genetically modified plants, The EFSAJournal 48,

15 Syngenta Event GA21 Page 15 of 29 ubiquitous in nature. The specific changes present in the mepsps gene were introduced to specifically alter two amino acids in the mepsps protein. These specific changes confer tolerance to herbicide products containing glyphosate and were not introduced to enhance recombination or gene transfer. Southern analysis of Event GA21 has been performed and has shown that the origin of replication in the original transformation vector has not been transferred to Event GA21. The only sequence of bacterial origin in GA21 is the nos terminator, which has been derived from Agrobacterium tumefaciens. This sequence is commonly used in the production of genetically modified plants and there is no evidence to suggest that the presence of this sequence enhances the potential of intact horizontal gene transfer from GM plants to bacteria. b) Plant to plant gene transfer The genetic modification in Event GA21 is not intended to change any of the typical crop characteristics of maize (except for the tolerance to herbicide products containing glyphosate). Observations from field trials have confirmed that the agronomic characteristics of Event GA21 have not changed in comparison with isogenic controls, and therefore, there is no increase or decrease in the potential for plant-to-plant gene transfer compared to traditional maize. Gene transfer from Event GA21 maize to other sexually compatible plant species is not possible since maize has no wild relatives in the EU. In addition, since the scope of this application does not include authorisation for the cultivation of Event GA21 maize, the likelihood of dissemination of pollen to other plants (including cultivated maize plants) is considered to be negligible. 7. Information on any toxic, allergenic or other harmful effects on human or animal health arising from the GM food/feed 7.1 Comparative assessment Choice of the comparator Event GA21 was compared with relevant control maize lines that had not been genetically modified. Commercial varieties were also included in the comparison where possible.

16 Syngenta Event GA21 Page 16 of Production of material for comparative assessment a) number of locations, growing seasons, geographical spreading and replicates To confirm that Event GA21-derived maize plants are substantially equivalent to the nontransgenic isolines, replicate trials of transgenic and corresponding isogenic controls were planted. The locations of the trial sites were selected to be representative of the range of environmental conditions under which the hybrid varieties are expected to be grown. At each location, three replicate plots of each genotype were planted. b) the baseline used for consideration of natural variations The levels of multiple nutritive components were compared in maize kernels (grain) or whole plants (forage) produced from Event GA21-derived maize plants and simultaneously grown isogenic control plants. The mean values are also compared with the range of data published in the literature, where data was available. 7.3 Selection of materials and compounds for analysis Based on guidance of the OECD, grain from transgenic GA21-derived maize plants and isogenic non-transgenic control plants were analysed for proximates (including starch), minerals, amino acids and selected fatty acids, vitamins, anti-nutrients and secondary metabolites. Forage (whole plants) from transgenic GA21-derived maize plants and isogenic non transgenic control plants were analysed for proximates and minerals. No consistent pattern has emerged to suggest that biologically significant changes in composition or nutritive value of the grain or forage had occurred as an unintended result of transformation or expression of the mepsps transgene. These data support the conclusion that Event GA21 maize is compositionally equivalent to conventional maize, apart from the introduced trait of herbicide tolerance. 7.4 Agronomic traits The scope of the application does not include cultivation, however measurement and observation of agronomic characteristics can add to the assessment of unintended effects of the genetic modification.

17 Syngenta Event GA21 Page 17 of 29 Event GA21-derived hybrids were grown in the USA during 2004, and in Brazil in Up to 20 separate agronomic traits were assessed, although not all traits were recorded at all locations. The commercial Event GA21 hybrids and their near isogenic non-transgenic hybrids were compared. While some differences between transgenic and control were found to be significant, there were no consistent trends in the data across locations or hybrids that would indicate that any of these differences were due to the presence of the transgene. These differences were within the normal range of variation experienced in agronomic field trials conducted with transgenic events by Syngenta over the past decade. These data support the conclusion that Event GA21 maize is agronomically equivalent to conventional maize, apart from the introduced trait of herbicide tolerance. 7.5 Product specification Maize as a product has a history of safe use for human food and animal feed. No significant native toxins are reported to be associated with the genus Zea. The information presented in this application confirms that Event GA21 maize and products derived from it are not different from those of its conventional counterpart. 7.6 Effect of processing Maize from Event GA21 will be produced and processed in the same way as any non-gm maize and there is no evidence to suggest that the expression of the mepsps protein will influence this processing in any way. Presence of mepsps protein was quantitatively analysed in maize grain and standard wetmilled and dry-milled processing fractions, corn oil and corn chips from the maize grain derived from Event GA21 and the corresponding near-isogenic non-transgenic controls. Concentrations of mepsps were below the limit of detection in all of the wet-milled fractions. Quantifiable amounts of mepsps were found in the starting grain and all of the dry-milled fractions. The concentration of mepsps in both the corn chip and corn oil samples were below the limit of detection. 7.7 Anticipated intake/extent of use There are no anticipated changes to the intake/extent of use of maize as a result of the introduction of Event GA21 to the conventional maize supply. It is anticipated that the

18 Syngenta Event GA21 Page 18 of 29 introduction of Event GA21 will replace some of the maize in existing food and feed products. However, the genetic modification was not intended to change any of the compositional parameters in food and feed and this been shown to be the case through extensive compositional assessment. 7.8 Toxicology Safety assessment of newly expressed proteins Maize derived from Event GA21 expresses a modified EPSPS protein (mepsps). The mepsps protein is derived from Zea mays and is greater that 99.3% homologous to maize EPSPS. EPSPS proteins are ubiquitous in nature and will naturally be present in foods derived from plant and microbial sources. To demonstrate the safety of this protein a series of studies were conducted. The data obtained showed that the mepsps, is not structurally and functionally related to proteins that have the potential to adversely affect human or animal health. It is sensitive to heat and processing and is rapidly degraded in simulated gastric fluid. It shows no sequence homology with known toxins or allergens. In addition, an acute oral toxicity study of mepsps in mice confirmed that the protein is not acutely toxic to mice at the highest dose tested. Supplemental information was also provided by a 90-day whole food safety study in rodents and a poultry feeding study showing no adverse effects on rats and chickens Testing of new constituents other than proteins Maize is a common source of food and feed and has a long history of safe use. Event GA21 has been modified to express the mepsps protein. No other new constituents apart from this protein are expected to be produced in Event GA21 and compositional analyses have confirmed the substantial equivalence of GA21 compared to conventional maize. Therefore no testing of any other constituent is considered necessary Information on natural food and feed constituents The presence and levels of natural food and feed constituents such as macro- and micronutrients, secondary plant metabolites as well as natural toxins and antinutritional factors have been analysed in Event GA21 and compared with non-genetically modified isolines and data from the literature. These analyses showed that the levels of the components measured had not changed beyond the natural variation in maize. No consistent patterns emerged to suggest that biologically significant changes in composition or nutritive value of the grain or forage had occurred as an unintended result of the transformation process or expression of the transgene Testing of the whole GM food/feed

19 Syngenta Event GA21 Page 19 of 29 In addition to the compositional analysis, the wholesomeness and safety of maize Event GA21 was confirmed in a 90-day whole food safety study in rats and a 49-day poultry feeding study. The 90-day whole food safety study was conducted to observe the effect of Event GA21on rats. The incorporation of Event GA21 transgenic maize grain in diets fed to rats for at least 90 consecutive days produced no deleterious effects that were considered to be attributable to the inclusion of Event GA21 transgenic maize grain in the diet. The 49-day poultry feeding study was also conducted to evaluate whether standard poultry diets prepared with Event GA21 grain had any adverse effect on male or female broiler chickens as compared to diets prepared with non-transgenic isoline control grain and a commercial source of corn. The study showed that the transgenic corn had no deleterious effects on broiler chickens. 7.9 Allergenicity Assessment of allergenicity of the newly expressed protein Maize derived from Event GA21 expresses a modified EPSPS protein (mepsps). The mepsps protein is derived from Zea mays and is greater than 99.3% homologous to maize EPSPS. EPSPS proteins are ubiquitous in nature and will naturally be present in foods derived from plant and microbial sources. To assess the potential for allergenicity of the mepsps protein a series of studies were conducted. The data obtained showed that the mepsps is not derived from a known allergenic source, has no homology to known or putative allergens is rapidly degraded in simulated gastric fluid is sensitive to heat and processing From these data, it can be concluded that the mepsps protein expressed in Event GA21 maize plants is unlikely to be allergenic Assessment of allergenicity of the whole GM plant or crop Maize has been extensively cultivated and has a history of safe use for human food and animal feed. Maize is not considered to be an allergenic food crop and Event GA21 does not express any new proteins with allergenic characteristics Nutritional assessment of GM food/feed Nutritional assessment of GM food Genetically modified Event GA21 is not intended to change the nutritional status of individuals of populations or to be processed in products with enhanced functionality. Compositional analysis and whole food safety tests have demonstrated that no unexpected

20 Syngenta Event GA21 Page 20 of 29 alterations in nutrients and other food components have occurred and that no nutritional imbalances were introduced Nutritional assessment of GM feed Genetically modified Event GA21 is not intended to change the nutritional status of livestock animals. Compositional analysis and whole food safety tests have demonstrated that no unexpected alterations in nutrients and other food components have occurred and that no nutritional imbalances were introduced Post-market monitoring of GM food/feed As described in sections 7.1 to 7.10 above, the presence of Event GA21 in food and feed will not result in any nutritional changes, therefore post-market monitoring is not considered necessary. 8. Mechanism of interaction between the GM plant and target organisms (if applicable) Maize derived from Event GA21 expresses a mepsps protein that confers tolerance to herbicide products containing glyphosate. Since the only modified trait expressed by the GA21 maize is that of herbicide tolerance there are no target organisms in this case. 9. Potential changes in the interactions of the GM plant with the biotic environment resulting from the genetic modification 9.1 Persistence and invasiveness Cultivation of maize derived from Event GA21 in the EU is not within the scope of this application. In the unlikely event that small amounts of maize kernels of Event GA21 accidentally found their way into the environment their survival would be very unlikely as maize is highly domesticated and cannot survive without human intervention, especially under normal European climatic conditions. The expression of the mepsps protein does not affect the agronomic characteristics or weediness potential of Event GA21, as demonstrated in field trials conducted to evaluate the agronomic performance of this event in comparison with the isogenic control. In the unlikely event that these maize plants were to survive they could be easily controlled using any of the current agronomic measures taken to control other commercially available maize. In summary, the probability of the genetically modified plants becoming more persistent than the recipient or parental plants in agricultural habitats or more invasive in natural habitats as a result of importing maize kernels of this event into the EU can be considered negligible.

21 Syngenta Event GA21 Page 21 of Selective advantage or disadvantage Event GA21 plants have been modified to contain a modified mepsps gene to confer tolerance to herbicide products containing glyphosate. Maize is a highly domesticated plant and cannot survive without human intervention. Therefore, tolerance to herbicide products containing glyphosate would not increase the chances of maize survival under European conditions and would not confer any selective advantage. It is important to emphasise that cultivation of Event GA21 in the EU is not within the scope of this application. In the unlikely event that small amounts of maize kernels of Event GA21 accidentally found their way into the environment, this would represent extremely low levels of exposure and the survival of these kernels would be very unlikely for the reasons stated above. In addition, they could be easily controlled using any of the current agronomic measures taken to control other commercially available maize. In summary, the potential risk of the expression of the mepsps protein in Event GA21 maize resulting in a selective advantage to the plants under the scope of this application can be considered negligible. 9.3 Potential for gene transfer Gene transfer from Event GA21 maize to other sexually compatible plant species is not possible since there are not any maize wild relatives in the EU. Gene transfer from Event GA21 maize to other maize could occur through pollen dispersal during the cultivation of the crop. Maize is predominantly wind pollinated. Plants produce pollen for days and shed pollen typically remains viable only a short time. 98% of pollen settles to the ground within meters of its source. Cultivation of maize Event GA21 is not within the scope of this application. It is therefore highly unlikely that this maize could grow in any significant quantity in the EU. In the unlikely event that small amounts of grain from maize Event GA21 could accidentally find their way into the environment this would represent extremely low levels of exposure and the survival of these grain would be very unlikely for the reasons stated above. In addition, they could be easily controlled using any of the current agronomic measures taken to control other commercially available maize. Therefore maize derived from Event GA21 is extremely unlikely to flower and fertilise other varieties of maize in Europe. In summary, the potential for gene transfer between Event GA21 maize plants and other maize plants or sexually compatible wild relatives in the EU can be considered negligible under the scope of this application.

22 Syngenta Event GA21 Page 22 of Interactions between the GM plant and target organisms Since the scope of this application does not include cultivation of maize plants of Event GA21, there will not be significant direct or indirect interactions with target organisms. In addition as the only modified trait expressed by the GA21 maize is that of herbicide tolerance there are no target organisms in this case. 9.5 Interactions of the GM plant with non-target organisms Since the scope of this application does not include cultivation of maize plants of Event GA21, direct or indirect interactions with non-target organisms are highly unlikely. In the unlikely event that small amounts of grain from maize Event GA21 accidentally found their way into the environment this would represent extremely low levels of exposure and the survival of these grain would be very unlikely since any germinating grain could be easily controlled using any of the current agronomic measures taken to control other commercially available maize. In summary, immediate or delayed effects in the environment due to direct or indirect interactions between Event GA21 maize plants and non-target organisms can be considered highly unlikely under the scope of this application. 9.6 Effects on human health Event GA21 will be imported in the EU and could enter the food chain. Human exposure to this maize could therefore occur though food consumption. However, the recipient organism, maize, has a history of safe use throughout the world. Event GA21 expresses a mepsps protein conferring tolerance to herbicide products containing glyphosate. Studies comparing the composition of Event GA21 maize plants and non-modified maize have been performed. These studies lead to the conclusion that this maize is substantially equivalent to conventional maize. mepsps is sensitive to processing and heat and rapidly degraded in simulated gastric fluids. It shows no sequence homology with known toxins or allergens. In addition, the acute oral toxicity study conducted with mepsps in mice, confirmed that the protein is not acutely toxic to mice at the highest dose tested. No test substance related mortalities occurred during the study and no clinical signs attributable to the test substance were observed. There were no treatment related effects on body weight, food consumption or organ weights, nor were any treatment related effects observed following macroscopic or microscopic examination of tissues. An allergenicity assessment has been conducted showing that this protein is unlikely to be allergenic. The inserted DNA and the flanking regions have been sequenced. A detailed open reading frame analysis could find no evidence for sequences of ORFs with homology to known toxins

23 Syngenta Event GA21 Page 23 of 29 or allergens The wholesomeness and safety of maize Event GA21 was confirmed in a 90-day toxicity study in rats and a poultry feeding study, where no treatment related effects were observed and no differences with the non-gm controls were detected. In summary, it can be concluded that grain from maize Event GA21 is safe for food consumption and no differences in wholesomeness are expected with comparable non-gm maize varieties. 9.7 Effects on animal health Event GA21 will be imported in the EU and could enter the feed chain. Animal exposure to this maize could therefore occur though feed consumption. However, the recipient organism, maize, has a history of safe use throughout the world. Event GA21 expresses a mepsps protein conferring tolerance to herbicide products containing glyphosate. Studies comparing the composition of Event GA21 maize plants and non-modified maize have been performed. These studies lead to the conclusion that this maize is substantially equivalent to conventional maize. The mepsps protein is sensitive to processing and heat and rapidly degraded in simulated gastric fluids. It shows no sequence homology to known toxins or allergens. In addition, the acute oral toxicity study conducted with mepsps in mice, confirmed that the protein is not acutely toxic to mice at the highest dose tested. No test substance related mortalities occurred during the study and no clinical signs attributable to the test substance were observed. There were no treatment related effects on body weight, food consumption or organ weights, nor were any treatment related effects observed following macroscopic or microscopic examination of tissues. The inserted DNA has been sequenced. A detailed open reading frame analysis could find no evidence for ORFs which showed homology to known toxins or allergens. The wholesomeness and safety of maize Event GA21 was confirmed in a 90-day toxicity study in rats and a poultry feeding study, where no treatment related effects were observed and no differences with the non-gm controls were detected. In summary, it can be concluded that grain from maize Event GA21 is safe for feed consumption and no differences in wholesomeness are expected with comparable non-gm maize varieties. 9.8 Effects on biogeochemical processes Since the scope of this application does not include cultivation of maize plants of Event GA21, effects on biogeochemical processes are highly unlikely. In the unlikely event that small amounts of maize kernels of Event GA21 accidentally found their way into the environment their survival would be very unlikely as maize is highly domesticated and cannot survive without human intervention, especially under normal European climatic conditions. Moreover, if these plants were to survive they could be easily controlled using any of the

24 Syngenta Event GA21 Page 24 of 29 current agronomic measures taken to control other commercially available maize. In summary, effects on biogeochemical processes resulting from the use of Event GA21 under the scope of this application are highly unlikely. 9.9 Impacts of the specific cultivation, management and harvesting techniques The scope of this application does not include cultivation of maize plants of Event GA21 in the EU. 10. Potential interactions with the abiotic environment The scope of this application does not include cultivation of Event GA21 maize in the EU, therefore interactions of maize Event GA21 with the abiotic environment are highly unlikely. In the unlikely event that small amounts of maize kernels of event GA21 accidentally found their way into the environment these plants will not have different interactions with the abiotic environment to similar non-gm plants. They will not be able to survive under European climatic conditions, and if they would, they could easily be controlled using conventional agronomic measures normally used on commercial maize plants. 11. Environmental monitoring plan (not if application concerns only food and feed produced from GM plants, or containing ingredients produced from GM plants and if the applicant has clearly shown that environmental exposure is absent or will be at levels or in a form that does not present a risk to other living organisms or the abiotic environment) 11.1 General (risk assessment, background information) The scope of this application does not include cultivation of Event GA21 maize in the EU. Environmental exposure to Event GA21 could only occur in the unlikely event that small amounts of grain of maize Event GA21 accidentally found their way into the environment in the EU. However, the survival of this grain would be very unlikely as maize is a highly domesticated plant and cannot survive without human intervention, especially under normal European climatic conditions. This grain, if germinated could be easily controlled using any of the current agronomic measures taken to control other commercially available maize. An environmental risk assessment (e.r.a.) has been conducted as recommended by the Guidance document of the EFSA Scientific Panel of Genetically Modified Organisms for the risk assessment of genetically modified plants and derived food and feed. According to this guidance the e.r.a. should follow the principles outlined in Directive 2001/18/EC (Annex II). The risk assessment is described as a process of evaluation, including the identification of the attendant uncertainties, of the likelihood and severity of an adverse effect(s)/event(s) occurring to man or the environment following exposure under defined conditions to a risk source(s). This risk assessment has been conducted taking into account the scope of this application, which covers the import of grain for use as any other conventional maize grain,

25 Syngenta Event GA21 Page 25 of 29 but does not include the cultivation of Event GA21. A sequential approach to the e.r.a., as recommended by Commission Decision 2002/623/EC has been followed, so the characteristics of Event GA21 that may cause an adverse effect have been identified, their potential consequences evaluated, the likelihood of their occurrence assessed and the overall risk posed by each characteristic identified. Comparison of Event GA21 maize with conventional maize has been used as a baseline. The conclusions of this e.r.a. confirm that the effects to the environment arising from the use of Event GA21 can be considered as negligible as those from any other commercial maize, under the scope of this application Interplay between environmental risk assessment and monitoring In general two types of environmental monitoring can be described: a. case-specific monitoring, designed to evaluate potential adverse effects linked to the genetic modification, identified in the e.r.a. b. general surveillance, which is aimed to identify adverse unforeseen effects that were not anticipated in the environmental risk assessment. An environmental risk assessment (e.r.a.) has been conducted in accordance with Annex II of Directive 2001/18/EC to evaluate potential adverse effects of Event GA21 on human and animal health and the environment. The conclusions of this e.r.a. confirm that the potential risks to human and animal health or the environment arising from the placing on the market of Event GA21 maize can be considered negligible, under the scope of this application. Therefore, a case-specific monitoring plan is not considered necessary under the scope of this application. However, a general surveillance plan based on Annex II of the Directive 2001/18/EC is outlined below Case-specific GM plant monitoring (approach, strategy, method and analysis) An environmental risk assessment (e.r.a.) has been conducted in accordance with Annex II of Directive 2001/18/EC to evaluate potential adverse effects of Event GA21 on human and animal health and the environment. The conclusions of this e.r.a. confirm that the potential risks to human and animal health or the environment arising from the placing on the market of Event GA21 maize can be considered negligible, under the scope of this application. Therefore, a case-specific monitoring plan is not considered necessary under the scope of this application. However, a general surveillance plan based on Annex II of the Directive 2001/18/EC is outlined below General surveillance of the impact of the GM plant (approach, strategy, method and analysis) The objective of general surveillance is to identify unforeseen adverse effects of the GM plant or its use, on human health and the environment, which were not predicted in the risk

26 Syngenta Event GA21 Page 26 of 29 assessment. The scope of this application is limited to import of Event GA21 and excludes cultivation practices. Cultivation outside the EU is accompanied by stewardship and surveillance programmes which include the provision of information to traders and processors of bulk mixtures of grain. The provisions concerning traceability and labelling for placing on the market of Event GA21 maize will allow the prompt identification of products containing or consisting of this maize, and thus enable any unanticipated adverse effects to be effectively traced. The majority of imported Event GA21 material will be used for feed purposes. Therefore, traders and processors as well as the European feed industry serve as a good focal point to address questions related to any unanticipated effects that might be associated with the use of Event GA21. Syngenta is committed to inform traders, processors and the European feed and food industry with details on the safety of Event GA21 and to establish a communication network where unforeseen effects can be reported. If unusual observations are reported, more focussed indepth studies can be carried out in order to determine cause and relationship with the specific event. Final decisions on whether any identified effects are significant can only be made if causality is clear and endpoints are determined. Although not a formal part of the surveillance plan, it is appropriate to note that there is an extensive information network, with global reach, which will provide additional information on possible adverse effects arising from the use of GM crops. These include new and rapid means of access to information from across the globe through telecommunications, the media and Internet access. Through these means, many groups, including agronomists, ecologists, health professionals, and the general public now have unprecedented access to reports on the use world-wide of GM crops. In addition, electronic discussion sites, for example those of WHO, OECD, FAO, and consumer organisations, are valuable sources of information and communication for professionals and, in many cases, the general public Reporting the results of monitoring The notifier/consent holder is responsible, under Regulation (EC) No 1829/2003, to inform the Rapporteur and the Commission of the results of the surveillance. Consistent with the EFSA guidance, the notifier will submit a General Surveillance Report containing information related to the monitoring on an annual basis. 12. Detection and event-specific identification techniques for the GM plant A method for detection of Event GA21 has been developed by Syngenta. The proposed method is a real-time quantitative TaqMan PCR based on specific detection of Event GA21 genomic DNA.

Application for authorization of stacked MIR604 x GA21 maize in the European Union under Regulation (EC) No 1829/2003 PART II: SUMMARY

Application for authorization of stacked MIR604 x GA21 maize in the European Union under Regulation (EC) No 1829/2003 PART II: SUMMARY Syngenta MIR604 x GA21 maize Page 1 of 34 Application for authorization of stacked MIR604 x GA21 maize in the European Union under Regulation (EC) No 1829/2003 The information contained in this document

More information

Syngenta Event MIR604 Page 1 of 28 PART II: SUMMARY. Application for import and use of Event MIR604 maize derived products PART II: SUMMARY

Syngenta Event MIR604 Page 1 of 28 PART II: SUMMARY. Application for import and use of Event MIR604 maize derived products PART II: SUMMARY Syngenta Event MIR604 Page 1 of 28 Application for import and use of Event MIR604 maize derived products Syngenta Event MIR604 Page 2 of 28 A. GENERAL INFORMATION 1. Details of application a) Member State

More information

The genetically modified maize is proposed to be used as any other maize.

The genetically modified maize is proposed to be used as any other maize. Opinion of the Scientific Committee on Plants Regarding "Submission for Placing on the Market of Glufosinate Tolerant Corns ( Zea Mays) Transformation Event T25" by the Agrevo Company (NOTIFICATION C/F/95/12/07)

More information

EFSA-GMO-NL PART VII SUMMARY

EFSA-GMO-NL PART VII SUMMARY Pioneer Overseas Corporation, Inc. 4114 Maize Page 1 APPLICATION FOR AUTHORISATION OF GENETICALLY MODIFIED PLANTS AND DERIVED FOOD AND FEED IN ACCORDANCE WITH REGULATION (EC) No 1829/2003 4114 MAIZE (DP-ØØ4114-3

More information

Application for authorisation of SYHT0H2 soybean import in the European Union under Regulation (EC) No 1829/2003 PART VII: SUMMARY

Application for authorisation of SYHT0H2 soybean import in the European Union under Regulation (EC) No 1829/2003 PART VII: SUMMARY Application for authorisation of SYHT0H2 soybean import in the European Union under Regulation (EC) No 1829/2003 This document is complete as of July 2012. Since it is submitted as one part of a regulatory

More information

Official Journal of the European Union DIRECTIVES

Official Journal of the European Union DIRECTIVES L 67/30 9.3.2018 DIRECTIVES COMMISSION DIRECTIVE (EU) 2018/350 of 8 March 2018 amending Directive 2001/18/EC of the European Parliament and of the Council as regards the environmental risk assessment of

More information

Unique Identifier BPS-PHØ48-1. Part VII Summary

Unique Identifier BPS-PHØ48-1. Part VII Summary Application for Authorisation of Phytophthora Resistant Potato PH05-026-0048 for Food and Feed Uses, Processing and Cultivation according to Regulation (EC) No 1829/2003 Unique Identifier BPS-PHØ48-1 2011

More information

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a COUNCIL DECISION

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a COUNCIL DECISION COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 04.07.2002 COM(2002) 362 final Proposal for a COUNCIL DECISION establishing pursuant to Directive 2001/18/EC of the European Parliament and of the Council

More information

Summary Notification Information Format

Summary Notification Information Format BIJLAGE 12 Summary Notification Information Format A. General information A1. Details of notification Notification Number Member State Belgium Date of Acknowledgement Title of the Project Scientific field

More information

Developing New GM Products and Detection Methods

Developing New GM Products and Detection Methods Developing New GM Products and Detection Methods Dave Grothaus Monsanto Company Slides Thanks to: International Life Sciences Institute Crop Life International Indus try Colleagues Hope Hart - Syngenta

More information

(Questions No EFSA-Q and EFSA-Q ) Opinion adopted on 13 September 2007

(Questions No EFSA-Q and EFSA-Q ) Opinion adopted on 13 September 2007 Opinion of the Scientific Panel on Genetically Modified Organisms on applications (references EFSA-GMO-UK-2005-19 and EFSA-GMO-RX-GA21) for the placing on the market of glyphosate-tolerant genetically

More information

Import and processing of genetically modified maize MON87427xMON89034xMIR162xNK603

Import and processing of genetically modified maize MON87427xMON89034xMIR162xNK603 Import and processing of genetically modified maize MON87427xMON89034xMIR162xNK603 COGEM advice CGM/160824-01 The present application (EFSA/GMO/NL/2016/131) concerns import and processing of genetically

More information

Biosafety Issues and Risk Assessment in Transgenic Crops

Biosafety Issues and Risk Assessment in Transgenic Crops Biosafety Issues and Risk Assessment in Transgenic Crops K.C. Bansal National Research Centre on Plant Biotechnology Indian Agricultural Research Institute New Delhi 110 012 kailashbansal@hotmail.com Biotechnology

More information

PART II SUMMARY OF THE TRANSFORMED APPLICATION FOR 1507 MAIZE FOOD PRODUCTS IN ACCORDANCE WITH REGULATION (EC) 1829/2003

PART II SUMMARY OF THE TRANSFORMED APPLICATION FOR 1507 MAIZE FOOD PRODUCTS IN ACCORDANCE WITH REGULATION (EC) 1829/2003 PART II EFSA-GMO-NL-2004-02 Page 1 of 28 SUMMARY OF THE TRANSFORMED APPLICATION FOR 1507 MAIZE FOOD PRODUCTS IN ACCORDANCE WITH REGULATION (EC) 1829/2003 A. GENERAL INFORMATION 1. Details of application

More information

Decree of the Ministry of Social Affairs and Health on the deliberate release of genetically modified organisms

Decree of the Ministry of Social Affairs and Health on the deliberate release of genetically modified organisms Ministry of Social Affairs and Health, Finland N.B. Unofficial translation. Legally valid only in Finnish and Swedish No 110/2005 Decree of the Ministry of Social Affairs and Health on the deliberate release

More information

SCIENTIFIC OPINION. EFSA Panel on Genetically Modified Organisms (GMO) 2,3 ABSTRACT. European Food Safety Authority (EFSA), Parma, Italy

SCIENTIFIC OPINION. EFSA Panel on Genetically Modified Organisms (GMO) 2,3 ABSTRACT. European Food Safety Authority (EFSA), Parma, Italy SCIENTIFIC OPINION Scientific Opinion on application (EFSA-GMO-UK-2008-60) for placing on the market of genetically modified herbicide tolerant maize GA21 for food and feed uses, import, under Regulation

More information

EFSA-GMO-NL-2016-XX. Part VII Summary

EFSA-GMO-NL-2016-XX. Part VII Summary Application for authorisation in the European Union of DAS-81419-2 DAS-44406-6 soybean grain for all uses as for any other soybean, excluding cultivation, according to Articles 5 and 17 of Regulation (EC)

More information

NATIONAL BIOSAFETY AUTHORITY RISK ASSESSMENT REPORT

NATIONAL BIOSAFETY AUTHORITY RISK ASSESSMENT REPORT 1 NATIONAL BIOSAFETY AUTHORITY RISK ASSESSMENT REPORT APPLICATION FOR ENVIRONMENTAL RELEASE, CULTIVATION AND PLACING ON THE MARKET OF MON 810 EVENT IN MAIZE VARIETIES APPLICANT: KENYA AGRICULTURAL AND

More information

The EFSA Journal (2005) 308, 1-22

The EFSA Journal (2005) 308, 1-22 Opinion of the Scientific Panel on Genetically Modified Organisms on a request from the Commission related to the notification (Reference C/GB/02/M3/3) for the placing on the market of glyphosate-tolerant

More information

c) Name of the product (commercial and other names)

c) Name of the product (commercial and other names) Application under Regulation (EC) No 1829/2003 on genetically modified food and feed for authorization of 40-3-2 soybean for cultivation in the European Union Part II Summary A. GENERAL INFORMATION 1.

More information

(Question No EFSA-Q ) Opinion adopted on 13 October 2005

(Question No EFSA-Q ) Opinion adopted on 13 October 2005 Opinion of the Scientific Panel on Genetically Modified Organisms on an application (Reference EFSA-GMO-UK-2004-01) for the placing on the market of glyphosate-tolerant and insectresistant genetically

More information

Official Journal of the European Communities. (Acts whose publication is not obligatory) COMMISSION

Official Journal of the European Communities. (Acts whose publication is not obligatory) COMMISSION L 200/22 EN 30.7.2002 II (Acts whose publication is not obligatory) COMMISSION COMMISSION DECISION of 24 July 2002 establishing guidance notes supplementing AnnexII to Directive 2001/18/EC of the European

More information

Standards for Safety Assessments of Food Additives produced Using Genetically Modified Microorganisms

Standards for Safety Assessments of Food Additives produced Using Genetically Modified Microorganisms Standards for Safety Assessments of Food Additives produced Using Genetically Modified Microorganisms (Food Safety Commission Decision of March 25, 2004) Chapter 1 General Provisions No. 1 Background on

More information

c) Name of the product (commercial and other names)

c) Name of the product (commercial and other names) Application for renewal of the authorisation for continued marketing of existing 40-3-2 soybean products that were authorised under Directive 90/220/EEC (Decision 96/281/EC) and subsequently notified according

More information

APPLICATION FOR CONFINED FIELD TRIAL

APPLICATION FOR CONFINED FIELD TRIAL APPLICATION FOR CONFINED FIELD TRIAL INSTRUCTIONS: This application form must be completed for each plant species. The application may include more than one event of the same plant species as long as the

More information

PRINSIP BIOTEKNOLOGY. Application of Biotech on Plants, Agriculture

PRINSIP BIOTEKNOLOGY. Application of Biotech on Plants, Agriculture PRINSIP BIOTEKNOLOGY Application of Biotech on Plants, Agriculture Materi Traditional methods, selective breeding Recombinant DNA technology How to deliver genes in plants The major concerns about GMO

More information

THE RESULT OF DELIBERATE RELEASE INTO THE ENVIRONMENT OF GENETICALLY MODIFIED HIGHER PLANTS IN ACCORDANCE WITH ARTICLE 10 OF DIRECTIVE 2001/18/EC

THE RESULT OF DELIBERATE RELEASE INTO THE ENVIRONMENT OF GENETICALLY MODIFIED HIGHER PLANTS IN ACCORDANCE WITH ARTICLE 10 OF DIRECTIVE 2001/18/EC THE RESULT OF DELIBERATE RELEASE INTO THE ENVIRONMENT OF GENETICALLY MODIFIED HIGHER PLANTS IN ACCORDANCE WITH ARTICLE 10 OF DIRECTIVE 2001/18/EC 1 GENERAL INFORMATION 1.1 European notification number:

More information

SUMMARY OF APPLICATIONS FOR GENETICALLY MODIFIED PLANTSAND/OR DERIVED FOOD AND FEED

SUMMARY OF APPLICATIONS FOR GENETICALLY MODIFIED PLANTSAND/OR DERIVED FOOD AND FEED Application EFSA-GMO-NL-2009-1 SUMMARY OF APPLICATIONS FOR GENETICALLY MODIFIED PLANTSAND/OR DERIVED FOOD AND FEED A. GENERAL INFORMATION 1. Details of application a) Member State of application The Netherlands

More information

SCIENTIFIC OPINION. Abstract

SCIENTIFIC OPINION. Abstract SCIENTIFIC OPINION ADOPTED: 24 January 2018 doi: 10.2903/j.efsa.2018.5163 Assessment of genetically modified maize NK603 x MON810 for renewal of authorisation under Regulation (EC) No 1829/2003 (application

More information

EFSA-GMO-BE EFSA-Q

EFSA-GMO-BE EFSA-Q Application for authorization to place on the market MON 87427 MON 89034 NK603 Maize in the European Union, according to Regulation (EC) No 1829/2003 on genetically modified food and feed EFSA-GMO-BE-2013-117

More information

Summary. The risk assessment prepared by EFSA has considerable shortcomings. For example:

Summary. The risk assessment prepared by EFSA has considerable shortcomings. For example: Technical background for a complaint under Article 10 of Regulation (EC) No. 1367/2006 against the decision of the EU Commission to give market authorisation to herbicide-tolerant genetically modified

More information

Roundup Ready Soybean. Herbicide Tolerance. Key facts

Roundup Ready Soybean. Herbicide Tolerance. Key facts 40-3-2 Roundup Ready Soybean Herbicide Tolerance Key facts Monsanto Europe-Africa February 2009 40-3-2 Roundup Ready Soybean Soybean, a key crop Soybean (Glycine max) is a high-protein legume grown mainly

More information

EFSA-GMO-NL-2011-XX. Part VII Summary. Summary EFSA-GMO-NL doc. DAS-444Ø6-6 Dow AgroSciences and M.S. Technologies Page 1 of 23

EFSA-GMO-NL-2011-XX. Part VII Summary. Summary EFSA-GMO-NL doc. DAS-444Ø6-6 Dow AgroSciences and M.S. Technologies Page 1 of 23 Application for authorisation of DAS-444Ø6-6 soybean grain for all uses as for any other soybean, excluding cultivation, according to Articles 5 and 17 of Regulation (EC) No 1829/2003 on genetically modified

More information

Draft COMMISSION DECISION

Draft COMMISSION DECISION COMISIONOFTHEUROPEANCOMUNITIES Brussels, D003698/01 Draft COMMISSION DECISION of [ ] concerning the placing on the market, in accordance with Directive 2001/18/EC of the European Parliament and of the

More information

Unit 3: Sustainability and Interdependence

Unit 3: Sustainability and Interdependence Unit 3: Sustainability and Interdependence Sub-topic 3.2 Plant and Animal Breeding Page 1 of 17 On completion of this sub-topic I will be able to: understand that plant and animal breeding involves the

More information

SCIENTIFIC OPINION. EFSA Panel on Genetically Modified Organisms (GMO) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

SCIENTIFIC OPINION. EFSA Panel on Genetically Modified Organisms (GMO) 2, 3. European Food Safety Authority (EFSA), Parma, Italy SCIENTIFIC OPINION Scientific Opinion on application (EFSA-GMO-NL-2007-38) for the placing on the market of insect resistant and herbicide tolerant genetically modified maize MON89034 x NK603 under Regulation

More information

SCIENTIFIC OPINION. EFSA Panel on Genetically Modified Organisms (GMO) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

SCIENTIFIC OPINION. EFSA Panel on Genetically Modified Organisms (GMO) 2, 3. European Food Safety Authority (EFSA), Parma, Italy SCIENTIFIC OPINION Scientific Opinion on application (EFSA-GMO-NL-2007-38) for the placing on the market of insect resistant and herbicide tolerant genetically modified maize MON89034 x NK603 under Regulation

More information

The EFSA Journal (2006) 355, 1-23

The EFSA Journal (2006) 355, 1-23 Opinion of the Scientific Panel on Genetically Modified Organisms on an application (Reference EFSA-GMO-UK-2004-05) for the placing on the market of insect-protected and glufosinate and glyphosate-tolerant

More information

APPLICATION FOR INTENTIONAL INTRODUCTION (CONDUCT A TRIAL RELEASE) OF GENETICALLY MODIFIED ORGANISMS (GMOs) INTO THE ENVIRONMENT OF SOUTH AFRICA

APPLICATION FOR INTENTIONAL INTRODUCTION (CONDUCT A TRIAL RELEASE) OF GENETICALLY MODIFIED ORGANISMS (GMOs) INTO THE ENVIRONMENT OF SOUTH AFRICA DIRECTORATE GENETIC RESOURCES Private Bag X973, Pretoria, 0001 Harvest House Room 167, 30 Hamilton Street, Arcadia, Pretoria, 0002 Tel: 12 319 6382, Fax: 12 319 6298, E-mail: NompumeleloM@daff.gov.za APPLICATION

More information

Risk Assessment of GM Plants and Derived Food and Feed as Applied by the EFSA GMO Panel

Risk Assessment of GM Plants and Derived Food and Feed as Applied by the EFSA GMO Panel Risk Assessment of GM Plants and Derived Food and Feed as Applied by the EFSA GMO Panel Dr. Harry A. Kuiper Chair EFSA GMO Panel RIKILT - Institute of Food Safety, Wageningen University & Research Centre,

More information

Overview on International Standards for Phytosanitary Measures (ISPMs) and their application to living modified organisms (LMOs)

Overview on International Standards for Phytosanitary Measures (ISPMs) and their application to living modified organisms (LMOs) Feb 2016 ENG Overview on International Standards for Phytosanitary Measures (ISPMs) and their application to living modified organisms (LMOs) Prepared by the Secretariat of the International Plant Protection

More information

Import and processing of genetically modified soybean MON87769 expressing two desaturase genes

Import and processing of genetically modified soybean MON87769 expressing two desaturase genes Import and processing of genetically modified soybean MON87769 expressing two desaturase genes COGEM advice CGM/100414-01 Summary The present application of Monsanto Company (file EFSA/GMO/UK/2009/76)

More information

THE RESULT OF DELIBERATE RELEASE INTO THE ENVIRONMENT OF GENETICALLY MODIFIED HIGHER PLANTS IN ACCORDANCE WITH ARTICLE 10 OF DIRECTIVE 2001/18/EC

THE RESULT OF DELIBERATE RELEASE INTO THE ENVIRONMENT OF GENETICALLY MODIFIED HIGHER PLANTS IN ACCORDANCE WITH ARTICLE 10 OF DIRECTIVE 2001/18/EC THE RESULT OF DELIBERATE RELEASE INTO THE ENVIRONMENT OF GENETICALLY MODIFIED HIGHER PLANTS IN ACCORDANCE WITH ARTICLE 10 OF DIRECTIVE 2001/18/EC 1 GENERAL INFORMATION 1.1 European notification number:

More information

Bayer CropScience LP Summary_EFSA-GMO-RX-XXX.pdf CC1: 09 Jan 2018 Oilseed rape T45 Page 1 of 7

Bayer CropScience LP Summary_EFSA-GMO-RX-XXX.pdf CC1: 09 Jan 2018 Oilseed rape T45 Page 1 of 7 Oilseed rape T45 Page 1 of 7 Request for Renewal of the Authorization for placing on the market of products containing or produced from genetically modified oilseed rape T45 (ACS-BNØØ8-2) resulting from

More information

Preclinical Toxicology of GM Crops. Dr. B. Sesikeran, MD, FAMS Director National Institute of Nutrition (ICMR) Hyderabad

Preclinical Toxicology of GM Crops. Dr. B. Sesikeran, MD, FAMS Director National Institute of Nutrition (ICMR) Hyderabad Preclinical Toxicology of GM Crops Dr. B. Sesikeran, MD, FAMS Director National Institute of Nutrition (ICMR) Hyderabad 500 007 1 Status of genetic modification of crops Existing: Simple modifications

More information

SCIENTIFIC OPINION. Scientific Opinion of the Panel on Genetically Modified Organisms. (Questions No EFSA-Q , No EFSA-Q )

SCIENTIFIC OPINION. Scientific Opinion of the Panel on Genetically Modified Organisms. (Questions No EFSA-Q , No EFSA-Q ) The EFSA Journal (2009) 1137, 1-50 SCIENTIFIC OPINION Applications (references EFSA-GMO-NL-2005-22, EFSA-GMO-RX- NK603) for the placing on the market of the genetically modified glyphosate tolerant maize

More information

Molecular assessment of GMOs Ilona Kryspin Sørensen PhD DTU Food Division for Risk Assessment and Nutrition

Molecular assessment of GMOs Ilona Kryspin Sørensen PhD DTU Food Division for Risk Assessment and Nutrition Molecular assessment of GMOs Ilona Kryspin Sørensen PhD DTU Food Division for Risk Assessment and Nutrition Objective : to assess the level of documentation necessary for the evaluation of the insertion

More information

Corporation obtaining approval, the name of its representative, and the address of its main office

Corporation obtaining approval, the name of its representative, and the address of its main office Corporation obtaining approval, the name of its representative, and the address of its main office Monsanto Japan Limited Seiichiro Yamane, President Ginza Sanno Bldg. 8F 4-10-10, Ginza, Chuo-ku, Tokyo

More information

Re: Application for importation and trial release of Roundup Ready canola line RT73.

Re: Application for importation and trial release of Roundup Ready canola line RT73. Re: Application for importation and trial release of Roundup Ready canola line RT73. With reference to Monsanto s application for importation and trial release of Roundup Ready canola RT73, reference number

More information

Environmental Risk Assessment

Environmental Risk Assessment EFSA NGO Consultation: 22 February 2006 Guidance document for the risk assessment of genetically modified plants and derived food and feed Environmental Risk Assessment Chapter III D, Sections 8-10, Jeremy

More information

Genetically Modified Crops

Genetically Modified Crops page 1/7 Scientific Facts on Genetically Modified Crops Source document: FAO (2004) Summary & Details: GreenFacts Context - We are regularly confronted with genetically modified foods, be it in the news

More information

Environmental monitoring plan for soybean MON 89788

Environmental monitoring plan for soybean MON 89788 Environmental monitoring plan for soybean MON 89788 1. Introduction The GMO panel has carried out the scientific assessment of the genetically modified soybean MON89788 and considered that the soybean

More information

Part II Summary. Part II - Summary MON MON

Part II Summary. Part II - Summary MON MON Application for authorization of MON 88913 MON 15985 cotton in the European Union, according to Regulation (EC) No 1829/2003 on genetically modified food and feed Part II Summary Data protection. This

More information

NAPPO Regional Standards for Phytosanitary Measures (RSPM)

NAPPO Regional Standards for Phytosanitary Measures (RSPM) NAPPO Regional Standards for Phytosanitary Measures (RSPM) RSPM No. 14 Importation and Release (into the environment) of Transgenic Plants, in NAPPO Member Countries Module 1: Importation Into Contained

More information

Biosafety Issues and Bt cotton A case study. O. P. GOVILA Retd. Professor Genetics IARI

Biosafety Issues and Bt cotton A case study. O. P. GOVILA Retd. Professor Genetics IARI Biosafety Issues and Bt cotton A case study O. P. GOVILA Retd. Professor Genetics IARI Introduction Classical plant breeding is limited to the introduction of required characters into plant by genetic

More information

Application of U.S. EPA GLP Terminology for Selected Studies on Genetically-Engineered Crops. December 18, 2017

Application of U.S. EPA GLP Terminology for Selected Studies on Genetically-Engineered Crops. December 18, 2017 Application of U.S. EPA GLP Terminology for Selected Studies on Genetically-Engineered Crops December 18, 2017 Authored by: The GLP/GE Crop Working Group, A Work Group of the National Alliance of Independent

More information

Development of a GMO Crop Product. Laura Privalle, Ph.D. August 7, 2014

Development of a GMO Crop Product. Laura Privalle, Ph.D. August 7, 2014 1 Development of a GMO Crop Product Laura Privalle, Ph.D. August 7, 2014 2 Agenda/ Content Stages in the Development of a GMO Product Elite Event Selection Safety Assessment Summary 3 Biotechnology is

More information

EFSA-GMO-NL Part VII Summary

EFSA-GMO-NL Part VII Summary Application for authorisation in the European Union of DAS-68416-4 MON-89788-1 soybean grain for all uses as for any other soybean, excluding cultivation, according to Articles 5 and 17 of Regulation (EC)

More information

SCIENTIFIC REPORT OF EFSA

SCIENTIFIC REPORT OF EFSA The EFSA Scientific Report (2009) 293, 1-18 SCIENTIFIC REPORT OF EFSA Public Consultation on the Updated Guidance Document of the Scientific Panel on Genetically Modified Organisms (GMO) for the risk assessment

More information

COMMISSION OF THE EUROPEAN COMMUNITIES. Draft COMMISSION DECISION

COMMISSION OF THE EUROPEAN COMMUNITIES. Draft COMMISSION DECISION COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, D003697/01 Draft COMMISSION DECISION of [ ] concerning the placing on the market, in accordance with Directive 2001/18/EC of the European Parliament and

More information

Cultivation of genetically modified sugar beet H7-1. COGEM advice CGM/

Cultivation of genetically modified sugar beet H7-1. COGEM advice CGM/ Cultivation of genetically modified sugar beet H7-1 COGEM advice CGM/091026-01 The present application by KWS Saat AG and Monsanto Europe S.A. (file EFSA/GMO/DE/2008/63) concerns cultivation of the genetically

More information

How much evidence does it take for EFSA to admit they are unsure about safety? The case of genetically modified herbicide resistant rice LL62.

How much evidence does it take for EFSA to admit they are unsure about safety? The case of genetically modified herbicide resistant rice LL62. How much evidence does it take for EFSA to admit they are unsure about safety? The case of genetically modified herbicide resistant rice LL62. April 2009 SUMMARY Rice is a staple food for 2.5 billion people.

More information

Genetically Modified Organisms

Genetically Modified Organisms Genetically Modified Organisms 1 Genetically Modified Organisms Farmers have been genetically modifying plants for 1000s of years Must take undesirable traits with those selected for Modern technology

More information

GMO & Food Safety. Presented By: Dr. Yasser Mostafa Quality & Food Safety Manager MARS KSA

GMO & Food Safety. Presented By: Dr. Yasser Mostafa Quality & Food Safety Manager MARS KSA GMO & Food Safety Presented By: Dr. Yasser Mostafa Quality & Food Safety Manager MARS KSA Contents: What are genetically modified (GM) organisms and GM foods? Why are GM foods produced? Are GM foods assessed

More information

Corporation obtaining approval, the name of its representative, and the address of its main office

Corporation obtaining approval, the name of its representative, and the address of its main office Corporation obtaining approval, the name of its representative, and the address of its main office Du Pont Kabushiki Kaisha Akio Kobayashi, President Sanno Park Tower 2-11-1, Nagata-chou, Chiyoda-ku, Tokyo

More information

SCIENTIFIC OPINION. Abstract

SCIENTIFIC OPINION. Abstract SCIENTIFIC OPINION ADOPTED: 18 May 2017 doi: 10.2903/j.efsa.2017.4861 Scientific opinion on an application for renewal of authorisation for continued marketing of maize 59122 and derived food and feed

More information

Import and processing of maize Bt11xMIR604xGA21

Import and processing of maize Bt11xMIR604xGA21 Import and processing of maize Bt11xMIR604xGA21 COGEM advice CGM/081017-03 Summary The present application by Syngenta Seeds S.A.S. (file EFSA/GMO/UK/2008/56) concerns import and processing for use in

More information

MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question.

MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question. Quiz - Chapter 10 - Agriculture, Biotechnology, and the Future of Food MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question. 1) Monoculture. A) farming

More information

BIO1PS 2012 Plant Science Topic 4 Lectures 2 and 3 Introduction to Plant Biotechnology

BIO1PS 2012 Plant Science Topic 4 Lectures 2 and 3 Introduction to Plant Biotechnology BIO1PS 2012 Plant Science Topic 4 Lectures 2 and 3 Introduction to Plant Biotechnology Dr. Michael Emmerling Department of Botany Room 410 m.emmerling@latrobe.edu.au Some Key Words Agrobacterium Ti plasmid

More information

Unit 2: Metabolism and Survival Sub-Topic (2.7) Genetic Control of Metabolism (2.8) Ethical considerations in the use of microorganisms

Unit 2: Metabolism and Survival Sub-Topic (2.7) Genetic Control of Metabolism (2.8) Ethical considerations in the use of microorganisms Unit 2: Metabolism and Survival Sub-Topic (2.7) Genetic Control of Metabolism (2.8) Ethical considerations in the use of microorganisms Duncanrig Secondary JHM&MHC 2015 Page 1 of 18 On completion of this

More information

GM maize. Stakeholder Consultation on Animal Feeding Studies and in-vitro Studies in GMO Risk Assessment. (3-4 December 2012, Vienna)

GM maize. Stakeholder Consultation on Animal Feeding Studies and in-vitro Studies in GMO Risk Assessment. (3-4 December 2012, Vienna) Human Health Environment Socio-Economy GM maize Stakeholder Consultation on Animal Feeding Studies and in-vitro Studies in GMO Risk Assessment (3-4 December 2012, Vienna) www.grace-fp7.eu Top countries

More information

What is DNA? Gene (skin colour) Gene (iris colour)

What is DNA? Gene (skin colour) Gene (iris colour) What is DNA? Gene (skin colour) Adenine Thymine Gene (iris colour) Guanine Cytosine 1 is deoxyribonucleic acid, a molecule found in the cells of all living organisms. It carries the information responsible

More information

PART II FOR INDUSTRIAL USES. Alfred-Nobel-Strasse 50 Technologiepark 38 D Monheim am Rhein address:

PART II FOR INDUSTRIAL USES. Alfred-Nobel-Strasse 50 Technologiepark 38 D Monheim am Rhein  address: Bayer CropScience 1829/2003 GHB614 Cotton - Part II Page 1 of 22 PART II SUMMARY OF THE APPLICATION FOR REQUEST FOR AUTHORIZATION GLYPHOSATE-TOLERANT COTTON GHB614 FOR FOOD AND FEED USES, AND IMPORT AND

More information

Prepared and amended by Testbiotech, January 2014,

Prepared and amended by Testbiotech, January 2014, Technical background for a complaint under Article 10 of Regulation (EC) No. 1367/2006 against the decision of the EU Commission to give market authorisation to stacked maize MON89034 1507 MON88017 59122

More information

GENETICALLY MODIFIED ORGANISMS. Julian Kinderlerer

GENETICALLY MODIFIED ORGANISMS. Julian Kinderlerer GENETICALLY MODIFIED ORGANISMS Julian Kinderlerer Genetically modified? There has been enormous controversy around the world about human intervention in producing new varieties of organisms through the

More information

Procedures of Application for Safety Assessment of Foods and Food Additives Produced by Recombinant DNA Techniques

Procedures of Application for Safety Assessment of Foods and Food Additives Produced by Recombinant DNA Techniques Ministry of Health and Welfare Announcement No. 233 According to the Specifications and Standards for Foods, Food Additives and Other Related Products (Ministry of Health and Welfare Announcement No.370-December

More information

What is Biotechnology?

What is Biotechnology? What is Biotechnology? Biotechnology is a modern technology that makes use of organisms (or parts thereof) to: make or modify products; improve and develop microorganisms, plants or animals; or develop

More information

COMPREHENSIVE GLOSSARY OF TERMS

COMPREHENSIVE GLOSSARY OF TERMS COMPREHENSIVE GLOSSARY OF TERMS Accidental release: Any unintended release of regulated plant material into the environment, food and/or feed chains. For the purposes of these Guidelines, any breach of

More information

Considerations For The Use Of Animal Studies In The Risk Assessment Of Genetically Modified Plants

Considerations For The Use Of Animal Studies In The Risk Assessment Of Genetically Modified Plants Considerations For The Use Of Animal Studies In The Risk Assessment Of Genetically Modified Plants Laura Caneva, MSc Biotechnology Regulatory Affairs Specialist Bayer Crop Science Outline 1. Safety Assessment

More information

Environmental monitoring plan for soybean BPS- CV127-9

Environmental monitoring plan for soybean BPS- CV127-9 Environmental monitoring plan for soybean BPS- CV127-9 1. Introduction EFSA has carried out the scientific assessment of the genetically modified soybean BPS- CV127-9 and considered that the soybean BPS-CV127-9

More information

[ 2 ] [ 3 ] WHAT IS BIOTECHNOLOGY? HOW IS BIOTECHNOLOGY DIFFERENT FROM THE TRADITIONAL WAY OF IMPROVING CROPS?

[ 2 ] [ 3 ] WHAT IS BIOTECHNOLOGY? HOW IS BIOTECHNOLOGY DIFFERENT FROM THE TRADITIONAL WAY OF IMPROVING CROPS? WHAT IS BIOTECHNOLOGY? Biotechnology is a modern technology that makes use of organisms (or parts thereof) to make or modify products; improve and develop microorganisms, plants or animals; or develop

More information

Bilateral technical meeting between the EFSA Panel on Genetically Modified Organisms and AFSSA

Bilateral technical meeting between the EFSA Panel on Genetically Modified Organisms and AFSSA Bilateral technical meeting between the EFSA Panel on Genetically Modified Organisms and AFSSA AFSSA-EFSA Milan 10 december 2008 AFSSA working group on 2000 2000: Working group establishing GMO risk assessment

More information

RESULT OF DELIBERATE RELEASE INTO THE ENVIRONMENT OF GENETICALLY MODIFIED HIGHER PLANTS IN ACCORDANCE WITH ARTICLE 10 OF DIRECTIVE 2001/18/EC

RESULT OF DELIBERATE RELEASE INTO THE ENVIRONMENT OF GENETICALLY MODIFIED HIGHER PLANTS IN ACCORDANCE WITH ARTICLE 10 OF DIRECTIVE 2001/18/EC RESULT OF DELIBERATE RELEASE INTO THE ENVIRONMENT OF GENETICALLY MODIFIED HIGHER PLANTS IN ACCORDANCE WITH ARTICLE 10 OF DIRECTIVE 2001/18/EC 1 GENERAL INFORMATION 1.1 European notification number: B/RO/07/12

More information

Class IX Chapter 15 Improvement in Food Resources Science

Class IX Chapter 15 Improvement in Food Resources Science What do we get from cereals, pulses, fruits and vegetables? (i) Cereals provide us with carbohydrates. Also, they are a rich source of energy. (ii) Pulses give us proteins. (iii) Fruits and vegetables

More information

Question 1: What do we get from cereals, pulses, fruits and vegetables? (i) Cereals provide us with carbohydrates. Also, they are a rich source of energy. (ii) Pulses give us proteins. (iii) Fruits and

More information

Class IX Chapter 15 Improvement in Food Resources Science

Class IX Chapter 15 Improvement in Food Resources Science Class IX Chapter 15 Improvement in Food Resources Science Question 1: What do we get from cereals, pulses, fruits and vegetables? (i) Cereals provide us with carbohydrates. Also, they are a rich source

More information

Maize MON MON NK603

Maize MON MON NK603 Maize MON 87427 MON 89034 NK603 Organisation: The European GMO-free Citizens (De Gentechvrije Burgers) Country: The Netherlands Type: Others a. Assessment: b. Food Safety Assessment: Toxicology The conclusions

More information

Bt maize technologies: Insect pest control Anani Bruce

Bt maize technologies: Insect pest control Anani Bruce Bt maize technologies: Insect pest control Anani Bruce Training course on identification and management of biotic stresses in maize 8-10 December 2015, Islamabad 1. What is Bt? Outline 2. How does Bt work

More information

GUIDELINE FOR THE CONDUCT OF FOOD SAFETY ASSESSMENT OF FOODS PRODUCED USING RECOMBINANT-DNA MICROORGANISMS

GUIDELINE FOR THE CONDUCT OF FOOD SAFETY ASSESSMENT OF FOODS PRODUCED USING RECOMBINANT-DNA MICROORGANISMS -1- GUIDELINE FOR THE CONDUCT OF FOOD SAFETY ASSESSMENT OF FOODS PRODUCED USING RECOMBINANT-DNA MICROORGANISMS SECTION 1 SCOPE CAC/GL 46-2003 1. This Guideline supports the Principles for the Risk Analysis

More information

PART II SUMMARY GLUFOSINATE AMMONIUM-TOLERANT GENETICALLY MODIFIED OILSEED RAPE MS8/RF3

PART II SUMMARY GLUFOSINATE AMMONIUM-TOLERANT GENETICALLY MODIFIED OILSEED RAPE MS8/RF3 Bayer CropScience 1829/2003 MS8/RF3 - Part II Page 1 of 20 PART II SUMMARY OF THE REQUEST FOR RENEWAL, ACCORDING TO ARTICLES 11 AND 23, OF THE AUTHORIZATIONS NOTIFIED UNDER ARTICLES 8(1)(A) AND 20(1)(B)

More information

PREPUBLICATION CODEX PRINCIPLES AND GUIDELINES ON FOODS DERIVED FROM BIOTECHNOLOGY CONTENTS

PREPUBLICATION CODEX PRINCIPLES AND GUIDELINES ON FOODS DERIVED FROM BIOTECHNOLOGY CONTENTS PREPUBLICATION CODEX PRINCIPLES AND GUIDELINES ON FOODS DERIVED FROM BIOTECHNOLOGY CONTENTS PRINCIPLES FOR THE RISK ANALYSIS OF FOODS DERIVED FROM MODERN BIOTECHNOLOGY... 1 GUIDELINE FOR THE CONDUCT OF

More information

Tips for Biotech Trial Conduct

Tips for Biotech Trial Conduct Tips for Biotech Trial Conduct James A. Mickelson, Ph.D. Research Scientist Pioneer Hi-Bred International, Inc. Johnston, Iowa World-Wide GMO Acreage Introduction This increase in GMO acreage is the result

More information

Official Journal of the European Communities

Official Journal of the European Communities 12.10.2000 EN Official Journal of the European Communities L 258/43 COMMISSION DECISION of 27 September 2000 concerning the guidance notes for risk assessment outlined in AnnexIII of Directive 90/219/EEC

More information

Chapter 15: Improvement in Food Resources Science

Chapter 15: Improvement in Food Resources Science Chapter 15: Improvement in Food Resources Science Page No: 204 1. What do we get from cereals, pulses, fruits and vegetables? Cereals provide us with carbohydrates. Also, they are a rich source of energy.

More information

Environmental risk assessment for experimental releases. Jeremy Sweet. JT Environmental Consultants Ltd, Cambridge CB24 5JA, UK

Environmental risk assessment for experimental releases. Jeremy Sweet. JT Environmental Consultants Ltd, Cambridge CB24 5JA, UK Environmental risk assessment for experimental releases Jeremy Sweet JT Environmental Consultants Ltd, Cambridge CB24 5JA, UK GM crop Field Trial Applications to CAs Competent Authorities will require

More information

INTERNATIONAL TURKISH HOPE SCHOOL ACADEMIC YEAR CHITTAGONG SENIOR SECTION BIOLOGY HANDOUT SELECTIVE BREEDING, GM & CLONING CLASS 9 AND 10

INTERNATIONAL TURKISH HOPE SCHOOL ACADEMIC YEAR CHITTAGONG SENIOR SECTION BIOLOGY HANDOUT SELECTIVE BREEDING, GM & CLONING CLASS 9 AND 10 INTERNATIONAL TURKISH HOPE SCHOOL 2014 2015 ACADEMIC YEAR CHITTAGONG SENIOR SECTION BIOLOGY HANDOUT SELECTIVE BREEDING, GM & CLONING CLASS 9 AND 10 Name :... Date:... Selective Breeding Selective breeding

More information

Appendix 4. Insect Protected Maize Farmer Questionnaire - User s Manual

Appendix 4. Insect Protected Maize Farmer Questionnaire - User s Manual Appendix 4. Insect Protected Maize Farmer Questionnaire - User s Manual Insect Protected Maize Farmer Questionnaire USER S MANUAL 1 General introduction to the insect protected maize farmer questionnaire

More information

Gene Ecology versus Reductionism in Biology. Thomas Bøhn PhD Scientific Director, GenØk

Gene Ecology versus Reductionism in Biology. Thomas Bøhn PhD Scientific Director, GenØk Gene Ecology versus Reductionism in Biology Thomas Bøhn PhD Scientific Director, GenØk This talk Human as beaver Two contrasting knowledge systems Organisms are composed of traits coded by genes Understanding

More information

POSTRELEASE MONITORING REPORT

POSTRELEASE MONITORING REPORT Syngenta Agro SRL Victoria Park 73-81 Bucuresti-Ploiesti Str. Floor 4, 013685 Bucharest, Romania Correspondence address: Tel. +40 21 5281200 Fax. +40 21 5281299 e-mail: andrei.marutescu@syngenta.com POSTRELEASE

More information